This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1bl4

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1bl4.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1bl4.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1bl4| PDB=1bl4 | SCENE= }}
{{STRUCTURE_1bl4| PDB=1bl4 | SCENE= }}
-
'''FKBP MUTANT F36V COMPLEXED WITH REMODELED SYNTHETIC LIGAND'''
+
===FKBP MUTANT F36V COMPLEXED WITH REMODELED SYNTHETIC LIGAND===
-
==Overview==
+
<!--
-
FKBP ligand homodimers can be used to activate signaling events inside cells and animals that have been engineered to express fusions between appropriate signaling domains and FKBP. However, use of these dimerizers in vivo is potentially limited by ligand binding to endogenous FKBP. We have designed ligands that bind specifically to a mutated FKBP over the wild-type protein by remodeling an FKBP-ligand interface to introduce a specificity binding pocket. A compound bearing an ethyl substituent in place of a carbonyl group exhibited sub-nanomolar affinity and 1,000-fold selectivity for a mutant FKBP with a compensating truncation of a phenylalanine residue. Structural and functional analysis of the new pocket showed that recognition is surprisingly relaxed, with the modified ligand only partially filling the engineered cavity. We incorporated the specificity pocket into a fusion protein containing FKBP and the intracellular domain of the Fas receptor. Cells expressing this modified chimeric protein potently underwent apoptosis in response to AP1903, a homodimer of the modified ligand, both in culture and when implanted into mice. Remodeled dimerizers such as AP1903 are ideal reagents for controlling the activities of cells that have been modified by gene therapy procedures, without interference from endogenous FKBP.
+
The line below this paragraph, {{ABSTRACT_PUBMED_9724721}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 9724721 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_9724721}}
==About this Structure==
==About this Structure==
Line 39: Line 43:
[[Category: Isomerase]]
[[Category: Isomerase]]
[[Category: Rotamase]]
[[Category: Rotamase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 11:39:18 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jun 30 19:19:52 2008''

Revision as of 16:19, 30 June 2008

Image:1bl4.png

Template:STRUCTURE 1bl4

FKBP MUTANT F36V COMPLEXED WITH REMODELED SYNTHETIC LIGAND

Template:ABSTRACT PUBMED 9724721

About this Structure

1BL4 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity., Clackson T, Yang W, Rozamus LW, Hatada M, Amara JF, Rollins CT, Stevenson LF, Magari SR, Wood SA, Courage NL, Lu X, Cerasoli F Jr, Gilman M, Holt DA, Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10437-42. PMID:9724721

Page seeded by OCA on Mon Jun 30 19:19:52 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1bl4"
Personal tools